Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy

Procalcitonin (PCT) is a biomarker for diagnosing infections and guiding antibiotic therapy. In this study, we investigated whether PCT can predict survival and recovery at 28 days in critically ill patients with sepsis-induced acute kidney injury (SIAKI) receiving continuous renal replacement thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Il Young, Kim, Suji, Ye, Byung Min, Kim, Min Jeong, Kim, Seo Rin, Lee, Dong Won, Lee, Soo Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794048/
https://www.ncbi.nlm.nih.gov/pubmed/36574383
http://dx.doi.org/10.1371/journal.pone.0279561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794048/
https://www.ncbi.nlm.nih.gov/pubmed/36574383
http://dx.doi.org/10.1371/journal.pone.0279561

Ejemplares similares